Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2010
08/25/2010EP1778676B1 Hydantoin derivatives for the treatment of inflammatory disorders
08/25/2010EP1591443B1 Pyrazole derivative
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1541161B1 Tablet composition containing chinese orthodox medicine extract and process for producing the same
08/25/2010EP1481679B1 Antidepressant
08/25/2010EP1480627B1 Methods of reducing angiogenesis
08/25/2010EP1385857B1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1325920B1 N-substituted benzothiophenesulfonamide derivatives
08/25/2010CN1972955B Radiosensitizer
08/25/2010CN1872095B Drop pills of enhancing body immunity and fighting against senium
08/25/2010CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
08/25/2010CN101815532A Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient
08/25/2010CN101815517A Nerve cell death inhibitor
08/25/2010CN101810850A Mouth spraying agent containing cell growth factor and production method thereof
08/25/2010CN101810848A Traditional Chinese medicinal composite for reducing stress response of aquatic animals and preparation method and application thereof
08/25/2010CN101810837A Chinese medicinal composition for treating spontaneous sweating disease
08/25/2010CN101810813A Oxygen lack resistance composition for preventing and treating altitude stress and preparation method thereof
08/25/2010CN101810787A Chinese medicinal composition for treating dysphoria and preparation method thereof
08/25/2010CN101810693A Chinese medicament for treating postpartum cold sweat and preparation method thereof
08/25/2010CN101810676A Compound Chinese herbal medicine preparation and fancy carp growth promotion effect
08/25/2010CN101810608A Anti-tumor small molecule compound targeting at human phosphatidylethanolamine-bindingprotein-4
08/25/2010CN101283996B Application of clock wise D-methionine in preparing the medicine for preventing and curing the myelosuppression induced by radiation
08/25/2010CN101212963B The use of chlorogenic acid in the manufacture of medicaments for increasing the effect of bone marrow cells
08/25/2010CN101044908B High nutrition product developed from vertebra bone of freshwater eel
08/25/2010CN101041626B Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
08/25/2010CN101040879B Method for detecting the quality of pine pollen fingerprinting in the resistance-strengthening and stasis-dispersing plant medicine
08/24/2010US7781647 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781587 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781463 Enzyme inhibitors
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7780988 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
08/24/2010CA2557368C Polynucleotide participating in rheumatoid arthritis and utilization of the same
08/24/2010CA2490907C Amide derivative
08/24/2010CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/24/2010CA2348493C Textured and porous silicone rubber
08/24/2010CA2322716C Use of follistatin to modulate gdf-8 and bmp-11
08/24/2010CA2274985C Synthetic antisense oligodeoxynucleotides targeted to human acetylcholinesterase
08/24/2010CA2213560C Pharmaceutical compositions for controlled release of soluble receptors
08/24/2010CA2204512C Lgmd gene coding for a calcium dependent protease
08/19/2010WO2010093859A1 Material and methods for treating developmental disorders including comorbid and idiopathic autism
08/19/2010WO2010093061A1 Diazepinedione derivative
08/19/2010WO2010092974A1 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092660A1 Inhibitor of casein kinase 1δ and casein kinase 1ε
08/19/2010WO2010092154A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092114A1 Use of buffers for radionuclide complexation
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010WO2010042229A3 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
08/19/2010US20100211183 Chemical Mechanical Vapor Deposition Device for Production of Bone Substitute Material
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210729 Methods of inducing terminal differentiation
08/19/2010US20100210723 Lipase inhibitor
08/19/2010US20100210712 Short RNA Antagonist Compounds for the Modulation of Target mRNA
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210608 Therapeutic treatment
08/19/2010US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/19/2010US20100210543 Aldehyde-Tagged Protein-Based Drug Carriers and Methods of Use
08/19/2010US20100210527 Pro- and anti-angiogenic treatments
08/19/2010US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209525 Methods for preparing polymer microparticles
08/19/2010US20100209511 sustained release pharmaceutical formulation
08/19/2010US20100209504 Process for production of crystalline cellulose and tablets containing granules
08/19/2010US20100209503 Bitter Taste Masking Dosage Form
08/19/2010US20100209499 Solid Oral Dosage Form Containing an Enhancer
08/19/2010US20100209492 Targeted Liposomal Drug Delivery System
08/19/2010US20100209460 Anti-odor agent having disinfecting or bactericidal effect
08/19/2010US20100209458 Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
08/19/2010US20100209436 Method for treating diseases related to mitochondrial dysfunction
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209419 Method and formulation for treating adverse biological conditions
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209394 Mitogen activated protein kinase modulator
08/19/2010US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections
08/19/2010CA2789641A1 Diazepinedione derivative
08/19/2010CA2781830A1 Materials and methods for treating developmental disorders inclucing comorbid and idiopathic autism
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/18/2010EP2219031A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218719A1 Abcg2 inhibitor
08/18/2010EP2217560A1 Novel synthetic analogs of sphingolipids
08/18/2010EP2217549A2 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
08/18/2010EP2217239A2 Modulation of protein trafficking
08/18/2010EP2217233A1 Methods and compositions for treating hepatic diseases
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN1744906B Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 1564